Stock screenerAll disclosures →
EDGAR →
AKBA
Conviction 15HealthcareScan · Thu, Jun 25, 2026AKBA$1.04-2.36%
ResistanceSupportVol 14Vol MA14 6.97M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.04
Change-2.36%
Gap+0.47%
Rel volume1.77×
Avg volume6.01M
Avg $ vol5.94M
SMA 200.9876
SMA 501.15
SMA 2001.67
Price vs 50-10.24%
Price vs 200-37.97%
MA stackbearish
50/200 cross—
Supertrenddown · 1.11
RSI (14)49
MACD hist0.03
MACD crossbull · 9d
Stoch %K / %D67 / 76
ADX (14)27
+DI / −DI21 / 24
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.01%
ADR %6.98%
52w high4.01
52w low0.8729
From 52w high-74.19%
Above 52w low+18.57%
New 52w highNo
SqueezeOff
Bollinger width26.41%
%B0.68
Donchian pos66.91%
Donchian high1.14
Donchian low0.8227
AVWAP (52w high)1.90
vs AVWAP high-45.53%
AVWAP (52w low)0.9895
vs AVWAP low+4.60%
OBV trendUp
Chaikin MF (20)0.09
Today vs 20d1.77×
Avg vol (14d)6.97M
Avg vol (20d)6.01M
Avg $ vol (20d)5.94M
Market cap277.65M
RS 3m (vs SPY)-34.32%
RS 6m (vs SPY)-43.88%
RS line new highNo
Trend template0/8
Technical rank20.5
1 week+1.47%
1 month-0.48%
3 months-25.54%
6 months-37.65%
1 year-71.80%
YTD-33.23%
P/E-51.95
P/B10.14
P/S1.18
P/FCF4.10
EPS-0.0200
Div yield—
ROE-19.53%
ROA-1.47%
Debt/Eq1.79
Current1.40
EV/EBITDA6.52
Gross margin—
Net margin-2.26%
Rev growth47.46%
EPS growth92.30%
Price target4.67
Target upside351.21%
Analyst ratingBuy
Institutional44.00%
Ent. value163.89M
Revenue53.54M
Net income-9.05M
Gross profit—
Free cash flow67.7M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out268.26M
Employees194
ListedThu, Mar 20, 2014
Free float247.48M
Float %93.3%
Short interest27.42M
Days to cover4.1d
Short volume39.7%
Squeeze score54 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.03 · 2 est
Last EPS vs est−$0.03 vs −$0.01
Last surprise-200.0% miss
Setup gradeD
Conviction15 / 100
Pattern quality—
Tech rank20.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.39
Support0.8488
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AKBA
No recent disclosed trades by Congress in AKBA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AKBA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
ADAMS ADRIAN Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
ADAMS ADRIAN Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
Smith Cynthia Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
Smith Cynthia Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
Wolf Myles Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
FRIESON RON Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
ZUMWALT LEANNE M Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
ZUMWALT LEANNE M Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
ROGERS MICHAEL W Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
ROGERS MICHAEL W Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
SEC filings
EDGAR filings in AKBA · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.